Half-year Report
FIDELITY EUROPEAN TRUST PLC Half-Yearly Results for the six months ended 30 June 2025 (unaudited) Financial Highlights: The Board of Fidelity European Trust PLC (the “Company”) declares an interim dividend of 3.90 pence per share, an increase of 8.3% on the prior year. During the six months ended 30 June 2025, Fidelity European Trust PLC reported a total share price return of +16.7%, while the Benchmark Index, the FTSE World Europe ex UK, rose +14.3%. The Net Asset Value (NAV) return was +9.6% over the same timeframe. Banks and financials contributed positively to performance during the period, particularly Bankinter. Subject to shareholder approval, the proposed combination of Fidelity European Trust PLC and Henderson European Trust PLC will be effective on 26 September 2025. Contacts For further information, please contact: Smita Amin Company Secretary 01737 836347 Chairman’s Statement Update on Combination with Henderson European Trust PLC On 19 June 2025, Fidelity European Trust PLC (the “Company”) announced a proposed Combination of assets with those of Henderson European Trust plc (“HET”) pursuant to a scheme of reconstruction and members’ voluntary liquidation of HET (the “Combination”). As noted in the announcement there will be no changes to the existing investment objective or policy with the experienced and award-winning team of Sam Morse and Marcel Stötzel continuing as Portfolio Managers. BENEFITS OF THE COMBINATION The Board believes that, if implemented, the Combination will result in a number of benefits for both the Company’s and HET’s shareholders, as well as for future investors in the Combined Entity, including: · Unparalleled scale and enhanced profile: The Combined Entity is anticipated to have net assets of circa £2.1 billion. As the flagship UK closed-ended vehicle for investment in Europe, the Combined Entity is expected to benefit from enhanced profile and marketability. · Lower tiered management fees: Fidelity has agreed that, with effect from completion of the deal, the annual management fee payable by the Combined Entity will be reduced to: 0.70 per cent of net assets up to and including £400 million; 0.65 per cent of net assets in excess of £400 million up to and including £1.4 billion; and 0.55 per cent of net assets in excess of £1.4 billion (the “Revised Fee Arrangements”).1 This is currently expected to result in a blended annual management fee rate for the Combined Entity of 0.63 per cent of net assets on completion of the Combination. · Lower ongoing charges ratio (“OCR”): Owing to the Revised Fee Arrangements and the economies of scale of the Combined Entity, the Company’s OCR will reduce significantly, allowing it to achieve an illustrative OCR of 0.68%, representing a material improvement to the Company’s last reported OCR of 0.76% as at 31 December 2024. · Enhanced liquidity: The scale of the Combined Entity, as the UK’s largest and most liquid European-focused investment trust, is also expected to further enhance secondary market liquidity for the Company’s shareholders (including in relation to its enhanced discount management policy as described further below). · Significant cost contribution from Fidelity: Fidelity has agreed to make a material contribution towards the costs of the Proposals, equivalent to a waiver of 12 months of management fees that would otherwise be payable in respect of the net assets transferred to the Company from HET. This is expected to offset fully the direct transaction costs for the Company’s existing shareholders. 1 The Company currently pays an annual management fee of 0.85 per cent of net assets up to and including £400 million and 0.65 per cent of net assets in excess of £400 million. · Enhanced discount management policy: In the light of the Proposals, the Board has decided to enhance its discount management policy such that the Company will seek to maintain any discount to net asset value in mid-single digits in normal market conditions. I am pleased to note that work to facilitate the combination is progressing smoothly. A Circular to the Company’s shareholders, providing further details of the proposals and notice of a general meeting to be held on 15 September 2025 to approve the Combination, and a Prospectus in respect of the issue of new shares in connection with the acquisition of assets from HET, was published on 21 August 2025 and is available on the Company’s website at www.fidelity.co.uk/europe. It is intended that, following completion of the Combination, Vicky Hastings and Rutger Koopmans, both of whom are current HET Directors, will be appointed as non-executive Directors of the Company. The appointment of the prospective Directors, Vicky and Rutger, will ensure that there is representation on our Board for both the shareholders of HET (which was formerly Henderson European Focus Trust plc) and the former shareholders of Henderson EuroTrust plc (which combined with HET in 2024). I look forward to welcoming Vicky and Rutger to the Company’s Board and I am sure they will prove to be valuable additions. The Board of the Company will therefore initially consist of seven Directors, comprising the five current Directors of the Company and two current HET Directors, all of whom will be non-executive and are independent of the AIFM and the Investment Manager. Following nine years of service, Paul Yates will retire from the Board at the next annual general meeting (“AGM”) of the Company, which is expected to be held in May 2026, and will not stand for re-election. Following the 2026 AGM, the number of Directors will reduce to six Directors. I believe that the Combination with HET is a highly positive development for the Company with shareholders standing to benefit from lower charges, greater liquidity in the Company’s shares, an enhanced discount management policy, and a higher profile that will contribute towards making it the “go to trust” for investing in Europe. DAVINA WALTER Chairman 3 September 2025 Portfolio Managers’ Half-Yearly Review Performance Review During the first six months of the year the net asset value (“NAV”) total return was +9.6% compared to a total return of +14.3% for the FTSE World Europe ex UK Index which is the Company’s Benchmark Index. The share price total return was +16.7%, which is above the NAV total return because of a narrowing of the share price discount to NAV. (All figures in UK sterling.) Market Review Continental European markets rose in the first half of this year, as concerns about possible tariffs on goods exported to the US, were more than offset by the anticipation of several positive drivers. Investors expected the European Central Bank (ECB), and other European central banks, to continue to lower interest rates as inflation waned. They also applauded the intention of the new German government to accelerate its domestic fiscal stimulus via substantial increases in defence spending and investment in infrastructure. Some investors also hoped that peace in Ukraine, orchestrated by the US, would take pressure off energy prices in Europe and provide a boost to the revenues of those European companies that might help in the reconstruction of the country. This optimism regarding the future trajectory of European economic growth, and some concerns regarding the direction of US fiscal policy, also reignited the Euro which appreciated by almost 4% against UK sterling during the six month reporting period. So, in UK sterling terms, the continental European benchmark rose more than 14% with many of the constituent country markets hitting all-time highs – most notably Germany, given the above. This made continental European equities one of the better performing asset classes during the period, even outperforming US equities for the first time in many years. Continental European markets have also witnessed a substantial change in leadership in the past few quarters with the banking sector very much in the vanguard, after many years of being in the doldrums, post the Global Financial Crisis (GFC). Many other “value” sectors have also turned around, driven by the factors mentioned above and a sense that a corner has been turned in terms of long-term bond yields (and therefore discount rates). More specifically, defence stocks have rocketed on the expectation of increased orders as European nations show more urgency to raise spending to align with higher NATO targets. Portfolio Managers’ Report The Company’s NAV total return lagged the Company’s Benchmark over the six-month period. The gearing of the Company, given rising markets, was a positive contributor but this was more than offset by lacklustre stock-picking. Pleasingly, however, the discount narrowed significantly over the period, such that the share price rose more than the Benchmark. Novo Nordisk was the main detractor from performance during the period. Its share price suffered a significant de-rating on lower-than-expected prescription growth in the US due to growing competition in the obesity indication from compounding (manufacture and sale of copycat drugs) companies and Eli Lilly. This was exacerbated by the unexpected departure of the CEO, who presumably paid the price for this poor execution in their main market. We now think that this is a very cheap stock, given its prospective dividend growth, and we expect an improved operating performance in the US obesity market, especially as the manufacture and sale of copycat drugs is no longer permitted.
| Top Five Stock Contributors (on a relative basis) | Sector | Country | % |
| Bankinter | Financials | Spain | +0.7 |
| ABN AMRO Bank | Financials | Netherlands | +0.6 |
| Deutsche Börse Group | Financials | Germany | +0.4 |
| Intesa Sanpaolo | Financials | Italy | +0.3 |
| AXA | Financials | France | +0.3 |
| ========= |
| Top Five Stock Detractors (on a relative basis) | Sector | Country | % |
| Novo Nordisk | Healthcare | Denmark | -0.9 |
| Rheinmetall (not held) | Industrials | Germany | -0.6 |
| Partners Group | Financials | Switzerland | -0.6 |
| Puma | Consumer Discretionary | Germany | -0.5 |
| Assa Abloy | Industrials | Sweden | -0.5 |
| ========= |
| Fair Value | |||
| Asset Exposure | |||
| £’000 | %1 | £’000 | |
| Long Exposures – shares unless otherwise stated | |||
| ASML | |||
| Technology Hardware and Equipment | 94,588 | 5.6 | 94,588 |
| Roche | |||
| Pharmaceuticals and Biotechnology | 87,182 | 5.2 | 87,182 |
| SAP (shares and long CFD) | |||
| Software and Computer Services | 86,652 | 5.1 | 25,798 |
| Nestlé | |||
| Food Producers | 71,527 | 4.2 | 71,527 |
| Novo Nordisk | |||
| Pharmaceuticals and Biotechnology | 67,350 | 4.0 | 67,350 |
| TotalEnergies | |||
| Oil, Gas and Coal | 67,238 | 4.0 | 67,238 |
| L’Oréal | |||
| Personal Goods | 62,748 | 3.7 | 62,748 |
| Legrand (shares and long CFD) | |||
| Electronic and Electrical Equipment | 58,573 | 3.5 | 23,600 |
| Deutsche Börse Group | |||
| Investment Banking and Brokerage Services | 52,386 | 3.1 | 52,386 |
| AXA | |||
| Non-Life Insurance | 51,740 | 3.1 | 51,740 |
| Intesa Sanpaolo | |||
| Banks | 49,604 | 2.9 | 49,604 |
| Assa Abloy | |||
| Construction and Materials | 48,930 | 2.9 | 48,930 |
| 3i Group | |||
| Investment Banking and Brokerage Services | 48,905 | 2.9 | 48,905 |
| Kone | |||
| Industrial Engineering | 48,672 | 2.9 | 48,672 |
| EssilorLuxottica | |||
| Medical Equipment and Services | 47,146 | 2.8 | 47,146 |
| Sampo | |||
| Non-Life Insurance | 45,772 | 2.7 | 45,772 |
| KBC Group | |||
| Banks | 45,080 | 2.7 | 45,080 |
| Richemont | |||
| Personal Goods | 42,458 | 2.5 | 42,458 |
| Amadeus IT Group | |||
| Software and Computer Services | 42,029 | 2.5 | 42,029 |
| Linde (long CFD) | |||
| Chemicals | 41,796 | 2.4 | 183 |
| --------------- | --------------- | --------------- | |
| Twenty largest long exposures | 1,160,376 | 68.7 | 1,022,936 |
| Other long exposures | 647,376 | 38.4 | 615,958 |
| --------------- | --------------- | --------------- | |
| Total long exposures before long futures2,3 | 1,807,752 | 107.1 | 1,638,894 |
| ========= | ========= | ========= | |
| Long Futures | |||
| EURO STOXX 50 Future September 20253 | 51,040 | 3.0 | (252) |
| --------------- | --------------- | --------------- | |
| Gross Asset Exposure3,4 | 1,858,792 | 110.1 | |
| ========= | ========= | ||
| Portfolio Fair Value5 | 1,638,642 | ||
| Net current assets (excluding derivative assets and liabilities) | 49,102 | ||
| --------------- | |||
| Shareholders’ Funds (per Balance Sheet below) | 1,687,744 | ||
| ========= | |||
| Six months ended 30 June 2025 unaudited | Six months ended 30 June 2024 unaudited | Year ended 31 December 2024 audited | ||||||||
Notes | Revenue £’000 | Capital £’000 | Total £’000 | Revenue £’000 | Capital £’000 | Total £’000 | Revenue £’000 | Capital £’000 | Total £’000 | |
| Gains/(losses) on investments | – | 86,503 | 86,503 | – | 76,095 | 76,095 | – | (47,301) | (47,301) | |
| Gains on derivative instruments | – | 31,371 | 31,371 | – | 21,012 | 21,012 | – | 35,423 | 35,423 | |
| Income | 4 | 41,327 | – | 41,327 | 41,081 | – | 41,081 | 53,670 | – | 53,670 |
| Investment management fees | 5 | (1,446) | (4,337) | (5,783) | (1,437) | (4,311) | (5,748) | (2,878) | (8,634) | (11,512) |
| Other expenses | (494) | – | (494) | (521) | – | (521) | (1,063) | – | (1,063) | |
| Foreign exchange gains/(losses) | – | 2,158 | 2,158 | – | (1,577) | (1,577) | – | (2,956) | (2,956) | |
| --------------- | --------------- | --------------- | --------------- | --------------- | --------------- | --------------- | --------------- | --------------- | ||
| Net return/(loss) on ordinary activities before finance costs and taxation | 39,387 | 115,695 | 155,082 | 39,123 | 91,219 | 130,342 | 49,729 | (23,468) | 26,261 | |
| Finance costs | 6 | (956) | (2,870) | (3,826) | (1,488) | (4,463) | (5,951) | (2,770) | (8,309) | (11,079) |
| --------------- | --------------- | --------------- | --------------- | --------------- | --------------- | --------------- | --------------- | --------------- | ||
| Net return/(loss) on ordinary activities before taxation | 38,431 | 112,825 | 151,256 | 37,635 | 86,756 | 124,391 | 46,959 | (31,777) | 15,182 | |
| Taxation on return/(loss) on ordinary activities | 7 | (2,330) | – | (2,330) | (3,391) | – | (3,391) | (4,422) | – | (4,422) |
| --------------- | --------------- | --------------- | --------------- | --------------- | --------------- | --------------- | --------------- | --------------- | ||
| Net return/(loss) on ordinary activities after taxation for the period | 36,101 | 112,825 | 148,926 | 34,244 | 86,756 | 121,000 | 42,537 | (31,777) | 10,760 | |
| ========= | ========= | ========= | ========= | ========= | ========= | ========= | ========= | ========= | ||
| Return/(loss) per ordinary share | 8 | 8.84p | 27.62p | 36.46p | 8.38p | 21.22p | 29.60p | 10.41p | (7.78p) | 2.63p |
| ========= | ========= | ========= | ========= | ========= | ========= | ========= | ========= | ========= | ||
Notes | Share capital £’000 | Share premium account £’000 | Capital redemption reserve £’000 | Capital reserve £’000 | Revenue reserve £’000 | Total shareholders’ funds £’000 | |
| Six months ended 30 June 2025 (unaudited) | |||||||
| Total shareholders’ funds at 31 December 2024 | 10,411 | 58,615 | 5,414 | 1,440,810 | 47,879 | 1,563,129 | |
| Repurchase of ordinary shares into Treasury | 11 | – | – | – | (1,831) | – | (1,831) |
| Net return on ordinary activities after taxation for the period | – | – | – | 112,825 | 36,101 | 148,926 | |
| Dividend paid to shareholders | 9 | – | – | – | – | (22,480) | (22,480) |
| --------------- | --------------- | --------------- | --------------- | --------------- | --------------- | ||
| Total shareholders’ funds at 30 June 2025 | 10,411 | 58,615 | 5,414 | 1,551,804 | 61,500 | 1,687,744 | |
| ========= | ========= | ========= | ========= | ========= | ========= | ||
| Six months ended 30 June 2024 (unaudited) | |||||||
| Total shareholders’ funds at 31 December 2023 | 10,411 | 58,615 | 5,414 | 1,472,587 | 40,452 | 1,587,479 | |
| Net return on ordinary activities after taxation for the period | – | – | – | 86,756 | 34,244 | 121,000 | |
| Dividend paid to shareholders | 9 | – | – | – | – | (20,396) | (20,396) |
| --------------- | --------------- | --------------- | --------------- | --------------- | --------------- | ||
| Total shareholders’ funds at 30 June 2024 | 10,411 | 58,615 | 5,414 | 1,559,343 | 54,300 | 1,688,083 | |
| ========= | ========= | ========= | ========= | ========= | ========= | ||
| Year ended 31 December 2024 (audited) | |||||||
| Total shareholders’ funds at 31 December 2023 | 10,411 | 58,615 | 5,414 | 1,472,587 | 40,452 | 1,587,479 | |
| Net (loss)/return on ordinary activities after taxation for the year | – | – | – | (31,777) | 42,537 | 10,760 | |
| Dividends paid to shareholders | 9 | – | – | – | – | (35,110) | (35,110) |
| --------------- | --------------- | --------------- | --------------- | --------------- | --------------- | ||
| Total shareholders’ funds at 31 December 2024 | 10,411 | 58,615 | 5,414 | 1,440,810 | 47,879 | 1,563,129 | |
| ========= | ========= | ========= | ========= | ========= | ========= |
Notes | 30 June 2025 unaudited £’000 | 31 December 2024 audited £’000 | 30 June 2024 unaudited £’000 | |
| Fixed assets | ||||
| Investments | 10 | 1,638,710 | 1,487,772 | 1,626,177 |
| --------------- | --------------- | --------------- | ||
| Current assets | ||||
| Derivative instruments | 10 | 1,198 | – | 5,348 |
| Debtors | 13,604 | 9,506 | 13,404 | |
| Amounts held at futures clearing houses and brokers | 3,708 | 10,078 | 4,545 | |
| Cash and cash equivalents | 33,148 | 63,042 | 42,633 | |
| --------------- | --------------- | --------------- | ||
| 51,658 | 82,626 | 65,930 | ||
| ========= | ========= | ========= | ||
| Current liabilities | ||||
| Derivative instruments | 10 | (1,266) | (5,796) | (2,615) |
| Other creditors | (1,358) | (1,473) | (1,409) | |
| --------------- | --------------- | --------------- | ||
| (2,624) | (7,269) | (4,024) | ||
| ========= | ========= | ========= | ||
| Net current assets | 49,034 | 75,357 | 61,906 | |
| ========= | ========= | ========= | ||
| Net assets | 1,687,744 | 1,563,129 | 1,688,083 | |
| ========= | ========= | ========= | ||
| Capital and reserves | ||||
| Share capital | 11 | 10,411 | 10,411 | 10,411 |
| Share premium account | 58,615 | 58,615 | 58,615 | |
| Capital redemption reserve | 5,414 | 5,414 | 5,414 | |
| Capital reserve | 1,551,804 | 1,440,810 | 1,559,343 | |
| Revenue reserve | 61,500 | 47,879 | 54,300 | |
| --------------- | --------------- | --------------- | ||
| Total shareholders’ funds | 1,687,744 | 1,563,129 | 1,688,083 | |
| ========= | ========= | ========= | ||
| Net asset value per ordinary share | 12 | 413.43p | 382.44p | 413.01p |
| ========= | ========= | ========= |
| Six months ended 30.06.25 unaudited £’000 | Six months ended 30.06.24 unaudited £’000 | Year ended 31.12.24 audited £’000 | |
| Investment income | |||
| Overseas dividends | 36,792 | 33,375 | 42,870 |
| UK dividends | 1,228 | 957 | 1,654 |
| --------------- | --------------- | --------------- | |
| 38,020 | 34,332 | 44,524 | |
| ========= | ========= | ========= | |
| Derivative income | |||
| Income recognised from futures contracts | 1,174 | 1,659 | 2,468 |
| Dividends received on long CFDs | 1,614 | 3,536 | 3,972 |
| Interest received on CFDs | – | 180 | 329 |
| --------------- | --------------- | --------------- | |
| 2,788 | 5,375 | 6,769 | |
| ========= | ========= | ========= | |
| Investment and derivative income | 40,808 | 39,707 | 51,293 |
| ========= | ========= | ========= | |
| Other interest | |||
| Interest received on bank deposits, collateral and money market funds | 519 | 1,342 | 2,323 |
| Interest received on tax reclaims | – | 32 | 54 |
| --------------- | --------------- | --------------- | |
| 519 | 1,374 | 2,377 | |
| ========= | ========= | ========= | |
| Total income | 41,327 | 41,081 | 53,670 |
| ========= | ========= | ========= |
| Revenue £’000 | Capital £’000 | Total £’000 | |
| Six months ended 30 June 2025 (unaudited) | |||
| Investment management fees | 1,446 | 4,337 | 5,783 |
| --------------- | --------------- | --------------- | |
| Six months ended 30 June 2024 (unaudited) | |||
| Investment management fees | 1,437 | 4,311 | 5,748 |
| --------------- | --------------- | --------------- | |
| Year ended 31 December 2024 (audited) | |||
| Investment management fees | 2,878 | 8,634 | 11,512 |
| ========= | ========= | ========= |
| Revenue £’000 | Capital £’000 | Total £’000 | |
| Six months ended 30 June 2025 (unaudited) | |||
| Interest paid on bank deposits and collateral | 32 | 98 | 130 |
| Interest paid on CFDs | 664 | 1,993 | 2,657 |
| Costs recognised from futures contracts | 260 | 779 | 1,039 |
| --------------- | --------------- | --------------- | |
| 956 | 2,870 | 3,826 | |
| ========= | ========= | ========= | |
| Six months ended 30 June 2024 (unaudited) | |||
| Interest paid on bank deposits and collateral | 7 | 22 | 29 |
| Interest paid on CFDs | 1,145 | 3,435 | 4,580 |
| Costs recognised from futures contracts | 336 | 1,006 | 1,342 |
| --------------- | --------------- | --------------- | |
| 1,488 | 4,463 | 5,951 | |
| ========= | ========= | ========= | |
| Year ended 31 December 2024 (audited) | |||
| Interest paid on bank deposits and collateral | 15 | 43 | 58 |
| Interest paid on CFDs | 2,122 | 6,367 | 8,489 |
| Costs recognised from futures contracts | 633 | 1,899 | 2,532 |
| --------------- | --------------- | --------------- | |
| 2,770 | 8,309 | 11,079 | |
| ========= | ========= | ========= |
| Six months ended 30.06.25 unaudited £’000 | Six months ended 30.06.24 unaudited £’000 | Year ended 31.12.24 audited £’000 | |
| Overseas taxation | 2,330 | 3,391 | 4,422 |
| ========= | ========= | ========= |
| Six months ended 30.06.25 unaudited | Six months ended 30.06.24 unaudited | Year ended 31.12.24 audited | |
| Revenue return per ordinary share | 8.84p | 8.38p | 10.41p |
| Capital return/(loss) per ordinary share | 27.62p | 21.22p | (7.78p) |
| --------------- | --------------- | --------------- | |
| Total return per ordinary share | 36.46p | 29.60p | 2.63p |
| ========= | ========= | ========= |
| £’000 | £’000 | £’000 | |
| Net revenue return on ordinary activities after taxation | 36,101 | 34,244 | 42,537 |
| Net capital return/(loss) on ordinary activities after taxation | 112,825 | 86,756 | (31,777) |
| --------------- | --------------- | --------------- | |
| Net total return on ordinary activities after taxation | 148,926 | 121,000 | 10,760 |
| ========= | ========= | ========= |
| Number | Number | Number | |
| Weighted average number of ordinary shares held outside Treasury during the period | 408,505,385 | 408,730,523 | 408,730,523 |
| ========== | ========== | ========== |
| Six months ended 30.06.25 unaudited £’000 | Six months ended 30.06.24 unaudited £’000 | Year ended 31.12.24 audited £’000 | |
| Final dividend of 5.50 pence per ordinary share paid for the year ended 31 December 2024 | 22,480 | – | – |
| Interim dividend of 3.60 pence per ordinary share paid for the year ended 31 December 2024 | – | – | 14,714 |
| Final dividend of 4.99 pence per ordinary share paid for the year ended 31 December 2023 | – | 20,396 | 20,396 |
| --------------- | --------------- | --------------- | |
| 22,480 | 20,396 | 35,110 | |
| ========= | ========= | ========= |
| Classification | Input |
| Level 1 | Valued using quoted prices in active markets for identical assets |
| Level 2 | Valued by reference to inputs other than quoted prices included in level 1 that are observable (i.e. developed using market data) for the asset or liability, either directly or indirectly |
| Level 3 | Valued by reference to valuation techniques using inputs that are not based on observable market data |
30 June 2025 (unaudited) | Level 1 £’000 | Level 2 £’000 | Level 3 £’000 | Total £’000 |
| Financial assets at fair value through profit or loss | ||||
| Investments | 1,638,710 | – | – | 1,638,710 |
| Derivative instrument assets | – | 1,198 | – | 1,198 |
| --------------- | --------------- | --------------- | --------------- | |
| 1,638,710 | 1,198 | – | 1,639,908 | |
| ========= | ========= | ========= | ========= | |
| Financial liabilities at fair value through profit or loss | ||||
| Derivative instrument liabilities | (252) | (1,014) | – | (1,266) |
| ========= | ========= | ========= | ========= |
31 December 2024 (audited) | Level 1 £’000 | Level 2 £’000 | Level 3 £’000 | Total £’000 |
| Financial assets at fair value through profit or loss | ||||
| Investments | 1,487,772 | – | – | 1,487,772 |
| Derivative instrument assets | – | – | – | – |
| --------------- | --------------- | --------------- | --------------- | |
| 1,487,772 | – | – | 1,487,772 | |
| ========= | ========= | ========= | ========= | |
| Financial liabilities at fair value through profit or loss | ||||
| Derivative instrument liabilities | (1,121) | (4,675) | – | (5,796) |
| ========= | ========= | ========= | ========= |
30 June 2024 (unaudited) | Level 1 £’000 | Level 2 £’000 | Level 3 £’000 | Total £’000 |
| Financial assets at fair value through profit or loss | ||||
| Investments | 1,626,177 | – | – | 1,626,177 |
| Derivative instrument assets | 531 | 4,817 | – | 5,348 |
| --------------- | --------------- | --------------- | --------------- | |
| 1,626,708 | 4,817 | – | 1,631,525 | |
| ========= | ========= | ========= | ========= | |
| Financial liabilities at fair value through profit or loss | ||||
| Derivative instrument liabilities | – | (2,615) | – | (2,615) |
| ========= | ========= | ========= | ========= |
| 30 June 2025 unaudited | 31 December 2024 audited | 30 June 2024 unaudited | ||||
Number of shares | Nominal value £’000 | Number of shares | Nominal Value £’000 | Number of shares | Nominal value £’000 | |
| Issued, allotted and fully paid | ||||||
| Ordinary shares of2.5 pence each heldoutside of Treasury | ||||||
| Beginning of the period | 408,730,523 | 10,218 | 408,730,523 | 10,218 | 408,730,523 | 10,218 |
| Ordinary shares repurchased into Treasury | (500,000) | (13) | – | – | – | – |
| ----------------- | ----------------- | ----------------- | ----------------- | ----------------- | ----------------- | |
| End of the period | 408,230,523 | 10,205 | 408,730,523 | 10,218 | 408,730,523 | 10,218 |
| ========== | ========== | ========== | ========== | ========== | ========== | |
| Ordinary shares of2.5 pence each heldin Treasury1 | ||||||
| Beginning of the period | 7,717,387 | 193 | 7,717,387 | 193 | 7,717,387 | 193 |
| Ordinary shares repurchased into Treasury | 500,000 | 13 | – | – | – | – |
| ----------------- | ----------------- | ----------------- | ----------------- | ----------------- | ----------------- | |
| End of the period | 8,217,387 | 206 | 7,717,387 | 193 | 7,717,387 | 193 |
| ========== | ========== | ========== | ========== | ========== | ========== | |
| Total share capital | 10,411 | 10,411 | 10,411 | |||
| ========== | ========== | ========== | ||||
| 30.06.25 unaudited | 31.12.24 audited | 30.06.24 unaudited | |
| Total shareholders’ funds | £1,687,744,000 | £1,563,129,000 | £1,688,083,000 |
| Ordinary shares held outside of Treasury at the period end | 408,230,523 | 408,730,523 | 408,730,523 |
| Net asset value per ordinary share | 413.43p | 382.44p | 413.01p |
| ============ | ============ | ============ |
| Gross gearing Asset exposure | Net gearing Asset exposure | |||
| £’000 | %1 | £’000 | %1 | |
| 30 June 2025 (unaudited) | ||||
| Investments | 1,638,710 | 97.1 | 1,638,710 | 97.1 |
| Long CFDs | 169,042 | 10.0 | 169,042 | 10.0 |
| Long futures | 51,040 | 3.0 | 51,040 | 3.0 |
| --------------- | --------------- | --------------- | --------------- | |
| Total long exposures | 1,858,792 | 110.1 | 1,858,792 | 110.1 |
| Short CFDs | – | – | – | – |
| --------------- | --------------- | --------------- | --------------- | |
| Gross asset exposure/net market exposure | 1,858,792 | 110.1 | 1,858,792 | 110.1 |
| ========= | ========= | ========= | ========= | |
| Shareholders’ funds | 1,687,744 | 1,687,744 | ||
| ========= | ========= | |||
| Gearing2 | 10.1 | 10.1 | ||
| ========= | ========= | |||
| 31 December 2024 (audited) | ||||
| Investments | 1,487,772 | 95.2 | 1,487,772 | 95.2 |
| Long CFDs | 196,659 | 12.6 | 196,659 | 12.6 |
| Long futures | 54,743 | 3.5 | 54,743 | 3.5 |
| --------------- | --------------- | --------------- | --------------- | |
| Total long exposures | 1,739,174 | 111.3 | 1,739,174 | 111.3 |
| Short CFDs | – | – | – | – |
| --------------- | --------------- | --------------- | --------------- | |
| Gross asset exposure/net market exposure | 1,739,174 | 111.3 | 1,739,174 | 111.3 |
| ========= | ========= | ========= | ========= | |
| Shareholders’ funds | 1,563,129 | 1,563,129 | ||
| ========= | ========= | |||
| Gearing2 | 11.3 | 11.3 | ||
| ========= | ========= | |||
| 30 June 2024 (unaudited) | ||||
| Investments | 1,626,177 | 96.3 | 1,626,177 | 96.3 |
| Long CFDs | 179,614 | 10.7 | 179,614 | 10.7 |
| Long futures | 69,923 | 4.1 | 69,923 | 4.1 |
| --------------- | --------------- | --------------- | --------------- | |
| Total long exposures | 1,875,714 | 111.1 | 1,875,714 | 111.1 |
| Short CFDs | 12,990 | 0.8 | (12,990) | (0.8) |
| --------------- | --------------- | --------------- | --------------- | |
| Gross asset exposure/net market exposure | 1,888,704 | 111.9 | 1,862,724 | 110.3 |
| ========= | ========= | ========= | ========= | |
| Shareholders’ funds | 1,688,083 | 1,688,083 | ||
| ========= | ========= | |||
| Gearing2 | 11.9 | 10.3 | ||
| ========= | ========= | |||
| Six months ended 30.06.25 unaudited £’000 | Six months ended 30.06.24 unaudited £’000 | Year ended 31.12.24 audited £’000 | |
| Portfolio management services | 5,783 | 5,748 | 11,512 |
| Marketing services | 124 | 116 | 221 |
| ========= | ========= | ========= |
| Six months ended 30.06.25 unaudited £’000 | Year ended 31.12.24 audited £’000 | Six months ended 30.06.24 unaudited £’000 | |
| Portfolio management services | 1,004 | 972 | 970 |
| Marketing services | 39 | 53 | 55 |
| ========= | ========= | ========= |
| 2025 £’000 | |
| Chairman | 50,000 |
| Senior Independent Director | 36,500 |
| Chair of the Audit Committee | 39,000 |
| Director | 32,500 |
| ========= |
| Six months ended 30.06.25 unaudited | |
| Fleur Meijs | 28,970 |
| Milyae Park | 12,300 |
| Sir Ivan Rogers | 8,749 |
| Davina Walter | 60,067 |
| Paul Yates | 32,000 |
| ========= |